Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER).

Diabetes Obes Metab · 2026 · PMC12890754 · PMID 41491349

Europe PMC DOI

hedged sentence

0.0910

closest p · 1.8× alpha

0.0910

boldest claim

The sentences

did not reach statistical significancep = 0.091so close (0.05 < p ≤ 0.1)

3.2 MACE outcomes The differences in MACE‐3, which included CV‐related mortality instead of all‐cause mortality, did not reach statistical significance (HR 0.74; 95% CI 0.52–1.05; p = 0.091; Figure 3A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.